Cargando…

Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic

Background and Objectives: Globally, diabetes Mellitus (DM) is a life-threatening disease that, if it remains uncontrolled, can lead to mortality or serious complications. Despite the noticeable benefits of clinical pharmacist in managing diabetes, some institutions in Saudi Arabia are reluctant to...

Descripción completa

Detalles Bibliográficos
Autores principales: Alghadeer, Sultan M., Alsuwayni, Bashayr, Almuwayjid, Abdulmohsen K., Almadi, Mohammed S., Mubarak, Abdullah M., Khunayn, Rawan M. bin, Al-Arifi, Mohamed N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781258/
https://www.ncbi.nlm.nih.gov/pubmed/35056322
http://dx.doi.org/10.3390/medicina58010014
_version_ 1784638046711316480
author Alghadeer, Sultan M.
Alsuwayni, Bashayr
Almuwayjid, Abdulmohsen K.
Almadi, Mohammed S.
Mubarak, Abdullah M.
Khunayn, Rawan M. bin
Al-Arifi, Mohamed N.
author_facet Alghadeer, Sultan M.
Alsuwayni, Bashayr
Almuwayjid, Abdulmohsen K.
Almadi, Mohammed S.
Mubarak, Abdullah M.
Khunayn, Rawan M. bin
Al-Arifi, Mohamed N.
author_sort Alghadeer, Sultan M.
collection PubMed
description Background and Objectives: Globally, diabetes Mellitus (DM) is a life-threatening disease that, if it remains uncontrolled, can lead to mortality or serious complications. Despite the noticeable benefits of clinical pharmacist in managing diabetes, some institutions in Saudi Arabia are reluctant to establish a pharmacist-led diabetic clinic for monitoring and follow-up. The objective of this study is to assess the glycemic control by comparing the reduction in hemoglobin A1c (HbA1c) percentage between patients followed in the pharmacist-led diabetic clinics vs. those followed in physician-led diabetic clinics. Materials and Methods: A retrospective observational study with a 12-month follow-up were used to detect the difference in the glycemic control by comparing the reduction in HbA1c percentage from the baseline, and average changes in HbA1c, fasting blood glucose (FBG), blood pressure (BP), and lipid panel between the two groups. The level of self-care was assessed by Summary of Diabetes Self-Care Activities (SDSCA) Questionnaire. Results: The study involved 52 patients who visited the diabetic clinic at a community teaching hospital. Exactly 24 patients were followed by the pharmacist-led diabetic clinics, while 28 were followed by physician-led diabetic clinics. HbA1c baseline was 8.7% and 8.4% for pharmacist and physician, respectively. The average difference in HbA1c for the pharmacist-led diabetic clinics vs. the physician-led diabetic clinics was not statistically significant (8.67 vs. 8.56; p = 0.77). Moreover, no difference in the glucose profile, lipid panel, and blood pressure were seen between the two groups. However, the median HbA1c change from baseline between the two groups significantly favored the pharmacist-led clinic (0.7 vs. 0.003; p = 0.04).The average of responses in all four aspects of the SDSCA (diet, exercise, blood sugar testing, and foot care) was also higher among patients in the pharmacist-led diabetic clinic. Conclusions: Pharmacist-led diabetic clinics for glycemic control and follow-up showed efficient results that encourage the comprehensive and integral inter-professional patient care.
format Online
Article
Text
id pubmed-8781258
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87812582022-01-22 Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic Alghadeer, Sultan M. Alsuwayni, Bashayr Almuwayjid, Abdulmohsen K. Almadi, Mohammed S. Mubarak, Abdullah M. Khunayn, Rawan M. bin Al-Arifi, Mohamed N. Medicina (Kaunas) Article Background and Objectives: Globally, diabetes Mellitus (DM) is a life-threatening disease that, if it remains uncontrolled, can lead to mortality or serious complications. Despite the noticeable benefits of clinical pharmacist in managing diabetes, some institutions in Saudi Arabia are reluctant to establish a pharmacist-led diabetic clinic for monitoring and follow-up. The objective of this study is to assess the glycemic control by comparing the reduction in hemoglobin A1c (HbA1c) percentage between patients followed in the pharmacist-led diabetic clinics vs. those followed in physician-led diabetic clinics. Materials and Methods: A retrospective observational study with a 12-month follow-up were used to detect the difference in the glycemic control by comparing the reduction in HbA1c percentage from the baseline, and average changes in HbA1c, fasting blood glucose (FBG), blood pressure (BP), and lipid panel between the two groups. The level of self-care was assessed by Summary of Diabetes Self-Care Activities (SDSCA) Questionnaire. Results: The study involved 52 patients who visited the diabetic clinic at a community teaching hospital. Exactly 24 patients were followed by the pharmacist-led diabetic clinics, while 28 were followed by physician-led diabetic clinics. HbA1c baseline was 8.7% and 8.4% for pharmacist and physician, respectively. The average difference in HbA1c for the pharmacist-led diabetic clinics vs. the physician-led diabetic clinics was not statistically significant (8.67 vs. 8.56; p = 0.77). Moreover, no difference in the glucose profile, lipid panel, and blood pressure were seen between the two groups. However, the median HbA1c change from baseline between the two groups significantly favored the pharmacist-led clinic (0.7 vs. 0.003; p = 0.04).The average of responses in all four aspects of the SDSCA (diet, exercise, blood sugar testing, and foot care) was also higher among patients in the pharmacist-led diabetic clinic. Conclusions: Pharmacist-led diabetic clinics for glycemic control and follow-up showed efficient results that encourage the comprehensive and integral inter-professional patient care. MDPI 2021-12-22 /pmc/articles/PMC8781258/ /pubmed/35056322 http://dx.doi.org/10.3390/medicina58010014 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alghadeer, Sultan M.
Alsuwayni, Bashayr
Almuwayjid, Abdulmohsen K.
Almadi, Mohammed S.
Mubarak, Abdullah M.
Khunayn, Rawan M. bin
Al-Arifi, Mohamed N.
Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic
title Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic
title_full Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic
title_fullStr Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic
title_full_unstemmed Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic
title_short Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic
title_sort glycemic control and management in pharmacist-led diabetic clinic vs. physician-led diabetic clinic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781258/
https://www.ncbi.nlm.nih.gov/pubmed/35056322
http://dx.doi.org/10.3390/medicina58010014
work_keys_str_mv AT alghadeersultanm glycemiccontrolandmanagementinpharmacistleddiabeticclinicvsphysicianleddiabeticclinic
AT alsuwaynibashayr glycemiccontrolandmanagementinpharmacistleddiabeticclinicvsphysicianleddiabeticclinic
AT almuwayjidabdulmohsenk glycemiccontrolandmanagementinpharmacistleddiabeticclinicvsphysicianleddiabeticclinic
AT almadimohammeds glycemiccontrolandmanagementinpharmacistleddiabeticclinicvsphysicianleddiabeticclinic
AT mubarakabdullahm glycemiccontrolandmanagementinpharmacistleddiabeticclinicvsphysicianleddiabeticclinic
AT khunaynrawanmbin glycemiccontrolandmanagementinpharmacistleddiabeticclinicvsphysicianleddiabeticclinic
AT alarifimohamedn glycemiccontrolandmanagementinpharmacistleddiabeticclinicvsphysicianleddiabeticclinic